Description
Composition:
Each ml contains:
Fulvestrant IP 50 mg
Ethanol (96%) USP 10 % w/v
PACKING: 1 Vial Injection
INDICATIONS: Fulvestrant is indicated for
the treatment of hormone receptor positive
Metastatic Breast Cancer in
postmenopausal women with disease
progression following antiestrogen therapy
Reviews
There are no reviews yet.